Advaxis (NASDAQ:ADXS)

Advaxis (NASDAQ:ADXS)


Share Price
$ 1.27
Change
0.04 (3.25 %)
Market Cap
$10.19 m
Proactive Investors - Run By Investors For Investors

Advaxis

Advaxis is a development-stage biotechnology company with the focus on developing cancer vaccines that utilize multiple mechanisms of immunity.

EPIC: ADXS
Market: NASDAQ:ADXS
52-week High/Low: $24.450 / $1.220
Sector: Pharmaceuticals
Market Cap: $10.19 m
Website: www.advaxis.com
col 3
col 4
col 5
col 6

Advaxis Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use